News – San Diego Biotechnology Network

Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference

July 30, 2021 sandiegobiotech Comments Off

SAN DIEGO: SAN DIEGO, July 30, 2021 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine Sun, senior vice president and chief financial officer, will virtually represent the company in a fireside chat at the Canaccord Genuity 41st Annual Growth Conference Securities 2021 Virtual Health Care Conference on… Click here to view original post… […]

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results

July 29, 2021 sandiegobiotech Comments Off

SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report second quarter 2021 financial results after the U.S. financial markets close on Thursday, August 5, 2021. Oncternal’s management will host a… Click here to view original post… […]

NSF Invests $20M in UC San Diego-headquartered Artificial Intelligence (AI) Research Institute

July 29, 2021 sandiegobiotech Comments Off

The Institute for Learning-enabled Optimization at Scale will pursue foundational breakthroughs at the nexus of artificial intelligence and optimization. Advances will transform chip design, robotics, and commun… […]

Explora BioLabs Opens New Facility in San Carlos, Calif.

July 29, 2021 sandiegobiotech Comments Off

SAN CARLOS, Calif.: SAN CARLOS, Calif., July 29, 2021 /PRNewswire/ — Explora BioLabs, a national provider of industry-leading preclinical vivarium research space and management services based in San Diego, opened a new facility in the San Francisco Bay region on July 26, 2021. The facility, located in San Carlos between… Click here to view original post… […]

Ionis completes enrollment in pivotal NEURO-TTRansform study of eplontersen

July 29, 2021 sandiegobiotech Comments Off

CARLSBAD, Calif.: CARLSBAD, Calif., July 29, 2021 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced it has completed enrollment of NEURO-TTRansform, the company’s Phase 3 study of eplontersen, formerly AKCEA-TTR-LRx, for people with hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN). The company has exceeded the enrollment… Click here to view original post… […]

NuVasive Announces Second Quarter 2021 Financial Results

July 28, 2021 sandiegobiotech Comments Off

SAN DIEGO: SAN DIEGO, July 28, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2021. Second Quarter 2021 Highlights Net sales increased 44.8% to… Click here to view original post… […]

Heron Therapeutics Announces Publication of Results from HOPE (Helping Opioid Prescription Elimination), Showing ZYNRELEF™ Minimizes the Need for Opioids in a Real-World Setting, With 95% of Patients Experiencing an Opioid-free Recovery

July 28, 2021 sandiegobiotech Comments Off

SAN DIEGO: SAN DIEGO, July 28, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced the results from the HOPE Hernia-1 study of ZYNRELEF… Click here to view original post… […]

Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

July 28, 2021 sandiegobiotech Comments Off

SAN DIEGO: SAN DIEGO, July 28, 2021 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the second quarter and six months ended June 30, 2021, and provided an… Click here to view original post… […]

Obesity and Cardiovascular Factors Combine to Cause Cognitive Decline in Latinos

July 28, 2021 sandiegobiotech Comments Off

Obesity is a major public health issue among Latinos, and a risk factor for Alzheimer’s disease. But in a new study, researchers at UC San Diego report that cardiometabolic abnormalities, such as hypertension, are more strongly associated with cognitive decline than obesity alone. Click here to view original post… […]

Obesity and Cardiovascular Factors Combine to Cause Cognitive Decline in Latinos

July 28, 2021 sandiegobiotech Comments Off

Obesity is a major public health issue among Latinos, and a risk factor for Alzheimer’s disease. But in a new study, researchers at UC San Diego report that cardiometabolic abnormalities, such as hypertension, are more strongly… […]